ACOTEC SCIEN.H. DL-00001 - Asset Resilience Ratio
ACOTEC SCIEN.H. DL-00001 (7W3) has an Asset Resilience Ratio of 18.64% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read ACOTEC SCIEN.H. DL-00001 (7W3) total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2023–2024)
This chart shows how ACOTEC SCIEN.H. DL-00001's Asset Resilience Ratio has changed over time. See net assets of ACOTEC SCIEN.H. DL-00001 for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down ACOTEC SCIEN.H. DL-00001's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 7W3 market cap overview.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €340.68 Million | 18.64% |
| Total Liquid Assets | €340.68 Million | 18.64% |
Asset Resilience Insights
- Good Liquidity Position: ACOTEC SCIEN.H. DL-00001 maintains a healthy 18.64% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
ACOTEC SCIEN.H. DL-00001 Industry Peers by Asset Resilience Ratio
Compare ACOTEC SCIEN.H. DL-00001's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
INKON Life Technology Co Ltd
SHE:300143 |
Medical Devices | 3.37% |
|
CareRay Digital Medical Technology Co Ltd
SHG:688607 |
Medical Devices | 16.21% |
|
Senseonics Holdings, Inc. Common Stock
NYSE MKT:SENS |
Medical Devices | 54.67% |
|
Universus Photo Imagings Limited
NSE:UNIVPHOTO |
Medical Devices | 30.97% |
|
HansBiomed Corporation
KQ:042520 |
Medical Devices | 9.13% |
|
Aligned Genetics Inc
KQ:238120 |
Medical Devices | 2.22% |
|
Heramed Ltd
AU:HMD |
Medical Devices | 0.83% |
|
Acarix A/S
ST:ACARIX |
Medical Devices | 37.81% |
Annual Asset Resilience Ratio for ACOTEC SCIEN.H. DL-00001 (2023–2024)
The table below shows the annual Asset Resilience Ratio data for ACOTEC SCIEN.H. DL-00001.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 6.78% | €112.80 Million ≈ $131.88 Million |
€1.66 Billion ≈ $1.94 Billion |
-8.21pp |
| 2023-12-31 | 15.00% | €241.58 Million ≈ $282.43 Million |
€1.61 Billion ≈ $1.88 Billion |
-- |
About ACOTEC SCIEN.H. DL-00001
Acotec Scientific Holdings Limited operates as an interventional medical device company that offers vascular interventional treatment products in Mainland China and internationally. The company's products include AcoArt Orchid & Dhalia, a paclitaxel DCB used to prevent stenosis or occlusion in superficial femoral artery and popliteal artery for the treatment of lower extremity artery disease with… Read more